Monitoring white blood cell mitochondrial aldehyde dehydrogenase activity: Implications for nitrate therapy in humans

Journal of Pharmacology and Experimental Therapeutics

Volumn 330, Issue 1, 2009, Pages 63-71

  Wenzel, Philip ^a   Schulz, Eberhard ^a   Gori, Tommaso ^a   Ostad, Mir A ^a   Mäthner, Falk ^a   Schildknecht, Stefan ^b   Göbel, Sebastian ^a   Oelze, Matthias ^a   Stalleicken, Dirk ^c   Warnholtz, Ascan ^a   Münzel, Thomas ^a   Daiber, Andreas ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b UNIVERSITY OF KONSTANZ   (Germany)

^c Actavis Deutschland GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE ISOENZYME 2; GLYCERYL TRINITRATE; LEUKOCYTE ENZYME; PENTAERYTHRITYL TETRANITRATE; THIOCTIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRACHIAL ARTERY; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG TOLERANCE; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN EXPERIMENT; MALE; NONHUMAN; NORMAL HUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; TACHYPHYLAXIS;

ALDEHYDE DEHYDROGENASE; ANIMALS; ENZYME ACTIVATION; HUMANS; LEUKOCYTES; MALE; MITOCHONDRIA, HEART; MYOCARDIAL ISCHEMIA; NITRATES; RATS; RATS, WISTAR; VASODILATION;

EID: 67649876089     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.108.149716     Document Type: Article

References (45)

1. Agvald P, Adding LC, Gustafsson LE, and Persson MG (1999) Nitric oxide generation, tachyphylaxis and cross-tachyphylaxis from nitrovasodilators in vivo. Eur J Pharmacol 385:137-145.
2. Anderson TJ, Meredith IT, Ganz P, Selwyn AP, and Yeung AC (1994) Nitric oxide and nitrovasodilators: similarities, differences and potential interactions. J Am Coll Cardiol 24:555-566. (Pubitemid 24246561)
3. Arnold WP, Mittal CK, Katsuki S, and Murad F (1977) Nitric oxide activates guanylate cyclase and increases guanosine 3′:5′-cyclic monophosphate levels in various tissue preparations. Proc Natl Acad Sci U S A 74:3203-3207. (Pubitemid 8180317)
4. Berkenboom G, Fang ZY, Unger P, and Fontaine J (1990) Effects of in vivo SIN1 treatment on nitrovasodilator relaxation and on EDRF-mediated responses in rat aorta. J Cardiovasc Pharmacol 16:636-640. (Pubitemid 20305821)
5. Cai H and Harrison DG (2000) Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87:840-844. (Pubitemid 30943820)
6. Chen CH, Budas GR, Churchill EN, Disatnik MH, Hurley TD, and Mochly-Rosen D (2008) Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart. Science 321:1493-1495.
7. Daiber A, August M, Baldus S, Wendt M, Oelze M, Sydow K, Kleschyov AL, and Munzel T (2004a) Measurement of NAD(P)H oxidase-derived superoxide with the luminol analogue L-012. Free Radic Biol Med 36:101-111. (Pubitemid 38068295)
8. Daiber A, Oelze M, Coldewey M, Bachschmid M, Wenzel P, Sydow K, Wendt M, Kleschyov AL, Stalleicken D, Ullrich V, et al. (2004b) Oxidative stress and mitochondrial aldehyde dehydrogenase activity: a comparison of pentaerythritol tetranitrate with other organic nitrates. Mol Pharmacol 66:1372-1382. (Pubitemid 39564764)
9. Daiber A, Oelze M, Sulyok S, Coldewey M, Schulz E, Treiber N, Hink U, Mülsch A, Scharffetter-Kochanek K, and Münzel T (2005) Heterozygous deficiency of manganese superoxide dismutase in mice (Mn-SOD+/-): a novel approach to assess the role of oxidative stress for the development of nitrate tolerance. Mol Pharmacol 68:579-588. (Pubitemid 41206011)
10. Daiber A, Wenzel P, Oelze M, and Münzel T (2008) New insights into bioactivation of organic nitrates, nitrate tolerance and cross-tolerance. Clin Res Cardiol 97:12-20.
11. Dragoni S, Gori T, Lisi M, Di Stolfo G, Pautz A, Kleinert H, and Parker JD (2007) Pentaerythritol tetranitrate and nitroglycerin, but not isosorbide mononitrate, prevent endothelial dysfunction induced by ischemia and reperfusion. Arterioscler Thromb Vasc Biol 27:1955-1959. (Pubitemid 47312304)
12. Dudek M, Bednarski M, Bilska A, Iciek M, Sokołowska-Jezewicz M, Filipek B, and Włodek L (2008) The role of lipoic acid in prevention of nitroglycerin tolerance. Eur J Pharmacol 591:203-210.
13. Esplugues JV, Rocha M, Nuñez C, Bosca I, Ibiza S, Herance JR, Ortega A, Serrador JM, D'Ocon P, and Victor VM (2006) Complex I dysfunction and tolerance to nitroglycerin: an approach based on mitochondrial-targeted antioxidants. Circ Res 99:1067-1075. (Pubitemid 44729930)
14. Gori T, Al-Hesayen A, Jolliffe C, and Parker JD (2003) Comparison of the effects of pentaerythritol tetranitrate and nitroglycerin on endothelium-dependent vasorelaxation in male volunteers. Am J Cardiol 91:1392-1394. (Pubitemid 36593497)
15. Gryglewski RJ, Zembowicz A, Salvemini D, Taylor GW, and Vane JR (1992) Modulation of the pharmacological actions of nitrovasodilators by methylene blue and pyocyanin. Br J Pharmacol 106:838-845.
16. Guo R, Chen XP, Guo X, Chen L, Li D, Peng J, and Li YJ (2008) Evidence for involvement of calcitonin gene-related peptide in nitroglycerin response and association with mitochondrial aldehyde dehydrogenase-2 (ALDH2) Glu504Lys polymorphism. J Am Coll Cardiol 52:953-960.
17. Hink U, Oelze M, Kolb P, Bachschmid M, Zou MH, Daiber A, Mollnau H, August M, Baldus S, Tsilimingas N, et al. (2003) Role for peroxynitrite in the inhibition of prostacyclin synthase in nitrate tolerance. J Am Coll Cardiol 42:1826-1834. (Pubitemid 37433665)
18. Hu R, Siu CW, Lau EO, Wang WQ, Lau CP, and Tse HF (2007) Impaired nitratemediated dilatation could reflect nitrate tolerance in patients with coronary artery disease. Int J Cardiol 120:351-356. (Pubitemid 47069561)
19. Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals, 7th ed, Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington, DC.
20. Jurt U, Gori T, Ravandi A, Babaei S, Zeman P, and Parker JD (2001) Differential effects of pentaerythritol tetranitrate and nitroglycerin on the development of tolerance and evidence of lipid peroxidation: a human in vivo study. J Am Coll Cardiol 38:854-859. (Pubitemid 32835764)
21. Münzel T, Daiber A, and Mülsch A (2005a) Explaining the phenomenon of nitrate tolerance. Circ Res 97:618-628.
22. Münzel T, Daiber A, Ullrich V, and Mülsch A (2005b) Vascular consequences of endothelial nitric oxide synthase uncoupling for the activity and expression of the soluble guanylyl cyclase and the cGMP-dependent protein kinase. Arterioscler Thromb Vasc Biol 25:1551-1557. (Pubitemid 41098921)
23. Münzel T, Sayegh H, Freeman BA, Tarpey MM, and Harrison DG (1995) Evidence for enhanced vascular superoxide anion production in nitrate tolerance: a novel mechanism underlying tolerance and cross-tolerance. J Clin Invest 95:187-194.
24. Oberle S, Abate A, Grosser N, Hemmerle A, Vreman HJ, Dennery PA, Schneider HT, Stalleicken D, and Schröder H (2003) Endothelial protection by pentaerythritol trinitrate: bilirubin and carbon monoxide as possible mediators. Exp Biol Med (Maywood) 228:529-534. (Pubitemid 37203672)
25. Oberle S, Schwartz P, Abate A, and Schröder H (1999) The antioxidant defense protein ferritin is a novel and specific target for pentaerythritol tetranitrate in endothelial cells. Biochem Biophys Res Commun 261:28-34. (Pubitemid 29371613)
26. Pearl RG, Rosenthal MH, Murad F, and Ashton JP (1984) Aminophylline potentiates sodium nitroprusside-induced hypotension in the dog. Anesthesiology 61:712-715. (Pubitemid 15223422)
27. Povsic TJ, Zavodni KL, Kelly FL, Zhu S, Goldschmidt-Clermont PJ, Dong C, and Peterson ED (2007) Circulating progenitor cells can be reliably identified on the basis of aldehyde dehydrogenase activity. J Am Coll Cardiol 50:2243-2248. (Pubitemid 350166817)
28. Radomski MW, Palmer RM, and Moncada S (1987) The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br J Pharmacol 92:639-646.
29. Schächinger V, Britten MB, and Zeiher AM (2000) Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101:1899-1906. (Pubitemid 30225269)
30. Schelling JL and Lasagna L (1967) A study of cross-tolerance to circulatory effects of organic nitrates. Clin Pharmacol Ther 8:256-260.
31. Schiewe R, Schnorbus B, Ostad MA, Medler C, Wenzel P, Daiber A, Munzel T, and Warnholtz A (2008) Pentaerithrityl tetranitrate does not deteriorate endothelial dysfunction in patients with coronary artery disease. A Prospective, Randomized, Double-blind, Placebo-controlled, Monocentric Clinical Trial (PENTA). Circulation 118 (Suppl. 2):S300.
32. Schildknecht S, Bachschmid M, and Ullrich V (2005) Peroxynitrite provides the peroxide tone for PGHS-2-dependent prostacyclin synthesis in vascular smooth muscle cells. FASEB J 19:1169-1171. (Pubitemid 40946454)
33. Schildknecht S, van der Loo B, Weber K, Tiefenthaler K, Daiber A, and Bachschmid MM (2008) Endogenous peroxynitrite modulates PGHS-1-dependent thromboxane A2 formation and aggregation in human platelets. Free Radic Biol Med 45:512-520.
34. Schulz E, Tsilimingas N, Rinze R, Reiter B, Wendt M, Oelze M, Woelken-Weckmüller S, Walter U, Reichenspurner H, Meinertz T, et al. (2002) Functional and biochemical analysis of endothelial (dys)function and NO/cGMP signaling in human blood vessels with and without nitroglycerin pretreatment. Circulation 105:1170-1175. (Pubitemid 34225816)
35. Sekiya M, Sato M, Funada J, Ohtani T, Akutsu H, and Watanabe K (2005) Effects of the long-term administration of nicorandil on vascular endothelial function and the progression of arteriosclerosis. J Cardiovasc Pharmacol 46:63-67. (Pubitemid 40917780)
36. Sydow K, Daiber A, Oelze M, Chen Z, August M, Wendt M, Ullrich V, Mülsch A, Schulz E, Keaney JF Jr, Stamler JS, and Münzel T (2004) Central role of mitochondrial aldehyde dehydrogenase and reactive oxygen species in nitroglycerin tolerance and cross-tolerance. J Clin Invest 113:482-489. (Pubitemid 38544192)
37. Thomas GR, DiFabio JM, Gori T, and Parker JD (2007) Once daily therapy with isosorbide-5-mononitrate causes endothelial dysfunction in humans: evidence of a free-radical-mediated mechanism. J Am Coll Cardiol 49:1289-1295. (Pubitemid 46476841)
38. Tsikas D (2000) Simultaneous derivatization and quantification of the nitric oxide metabolites nitrite and nitrate in biological fluids by gas chromatography/mass spectrometry. Anal Chem 72:4064-4072. (Pubitemid 30694755)
39. 15N]nitrosoalbumin as internal standard. J Chromatogr B Biomed Sci Appl 726:13-24.
40. Warnholtz A, Ostad MA, Heitzer T, Goldmann BU, Nowak G, and Munzel T (2005) Effect of tirofiban on percutaneous coronary intervention-induced endothelial dysfunction in patients with stable coronary artery disease. Am J Cardiol 95:20-23. (Pubitemid 40051106)
41. Wenzel P, Hink U, Oelze M, Schuppan S, Schaeuble K, Schildknecht S, Ho KK, Weiner H, Bachschmid M, Münzel T, et al. (2007a) Role of reduced lipoic acid in the redox regulation of mitochondrial aldehyde dehydrogenase (ALDH-2) activity. Implications for mitochondrial oxidative stress and nitrate tolerance. J Biol Chem 282:792-799. (Pubitemid 47076617)
42. Wenzel P, Hink U, Oelze M, Seeling A, Isse T, Bruns K, Steinhoff L, Brandt M, Kleschyov AL, Schulz E, et al. (2007b) Number of nitrate groups determines reactivity and potency of organic nitrates: a proof of concept study in ALDH-2-/- mice. Br J Pharmacol 150:526-533. (Pubitemid 46280655)
43. Wenzel P, Müller J, Zurmeyer S, Schuhmacher S, Schulz E, Oelze M, Pautz A, Kawamoto T, Wojnowski L, Kleinert H, et al. (2008a) ALDH-2 deficiency increases cardiovascular oxidative stress: evidence for indirect antioxidative properties. Biochem Biophys Res Commun 367:137-143.
44. Wenzel P, Oelze M, Coldewey M, Hortmann M, Seeling A, Hink U, Mollnau H, Stalleicken D, Weiner H, Lehmann J, et al. (2007c) Heme oxygenase-1: a novel key player in the development of tolerance in response to organic nitrates. Arterioscler Thromb Vasc Biol 27:1729-1735. (Pubitemid 47207167)
45. Wenzel P, Schuhmacher S, Kienhöfer J, Müller J, Hortmann M, Oelze M, Schulz E, Treiber N, Kawamoto T, Scharffetter-Kochanek K, et al. (2008b) Manganese superoxide dismutase and aldehyde dehydrogenase deficiency increase mitochondrial oxidative stress and aggravate age-dependent vascular dysfunction. Cardiovasc Res 80:280-289.